This strategic partnership positions Densitas, together with CancerIQ, to support care providers in meeting and exceeding their FDA MQSA EQUIP compliance, ACR Accreditation, and 2024 Accreditation requirements set by the National Accreditation Program for Breast Centers (NAPBC) that enhance clinical workflows and streamline the reporting status, both critical components for NAPBC accreditation. Together, the product suites offer care providers a blended solution for their breast health services, and deliver a powerful platform for deeper, data-driven understanding of mammography quality and patient risk profiles.
Integrated with leading EHRs, CancerIQ's lifetime risk calculator offers Tyrer-Cuzick scores (7 and 8), Gail, and NCCN guidelines, putting comprehensive risk scores at clinicians' fingertips. The platform also supports essential high-risk patient identification, genetic testing automation, education, navigation, and long-term care management.
Ad Statistics
Times Displayed: 47798
Times Visited: 1355 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
"Our work with Densitas reflects our vision to further enhance the innovative AI offerings industry-leading partners bring to the breast density and mammography quality space," said Feyi Ayodele, co-founder and CEO, CancerIQ. "We're thrilled to expand the CancerIQ family of partners to ensure more patients have access to genetically informed cancer prevention, treatment and survivorship care."
About Densitas
Densitas is a global leader in artificial intelligence solutions for breast cancer screening, focused on quality, safety, efficiency, and precision breast health. Densitas solutions support care providers delivering mammography services to improve efficiencies, meet FDA/ACR compliance requirements supporting early breast cancer detection and treatment. For more information, visit www.densitashealth.com.
About CancerIQ
CancerIQ is the only cancer-focused precision health platform that empowers healthcare providers to detect cancer earlier and prevent it altogether across all patient populations. Integrated directly into real-time EHR workflows, CancerIQ makes it easy to gather comprehensive patient data, automatically map it to the latest evidence-based guidelines, and expand access to personalized care plans, cutting-edge clinical solutions, and genomic innovations. Learn more at www.canceriq.com, follow CancerIQ on Twitter or LinkedIn.
Back to HCB News
